New drug combo aims to wipe out stomach tumors before surgery
Disease control
Recruiting now
This study tests whether adding the experimental drug IBI363 to standard chemotherapy can better shrink or eliminate stomach cancer before surgery. It includes 60 adults with a specific type of advanced stomach cancer that lacks a certain immune marker. The goal is to see if this…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC